Identifying early brain changes in Alzheimer's disease using advanced MRI techniques

Developing a validated biomarker of cortical neurodegeneration in Alzheimer's disease using high-gradient diffusion MRI

NIH-funded research Massachusetts General Hospital · NIH-11018569

This study is looking at how a special type of brain scan can help spot early signs of Alzheimer's disease in people who have mild memory issues or are at risk, so we can better understand how the disease develops before symptoms appear.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11018569 on NIH RePORTER

What this research studies

This research focuses on detecting early signs of Alzheimer's disease by using high-gradient diffusion MRI, a cutting-edge imaging technique. It aims to identify microscopic changes in brain structure that occur before the onset of noticeable symptoms. By comparing these imaging results with actual brain tissue samples, the study seeks to improve our understanding of how Alzheimer's progresses. Patients with mild cognitive impairment or those at risk for Alzheimer's will be the primary subjects of this investigation.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with mild cognitive impairment or those at risk of developing Alzheimer's disease.

Not a fit: Patients with advanced Alzheimer's disease or those without cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and better monitoring of Alzheimer's disease, potentially improving treatment outcomes.

How similar studies have performed: Previous research has shown promise in using advanced MRI techniques to detect early brain changes in Alzheimer's, indicating that this approach has potential for success.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease pathologyAlzheimer's disease patient
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.